<sentence id="0">O6-Methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas : PCR and immunohistochemistry .</sentence>
<sentence id="1">Ependymomas are the third most common brain tumor in children .</sentence>
<sentence id="2">The post surgical management is controversial .</sentence>
<sentence id="3">There are <scope type="neg" id="0"><cue type="neg" id="0">no</cue> convincing data on an effective role for chemotherapy</scope> .</sentence>
<sentence id="4">O(6)-Methylguanine-DNA-Methyltransferase ( MGMT ) is a DNA repair protein considered to be a chemosensitivity predictor .</sentence>
<sentence id="5">Hypermethylation of the MGMT gene promoter is an important cause of MGMT inactivation .</sentence>
<sentence id="6">We evaluated the MGMT gene promoter methylation and the immunohistochemical MGMT protein expression in 12 recurrent anaplastic ependymomas affecting children .</sentence>
<sentence id="7">Our purpose was to investigate the molecular rationale of the administration of alkylating agents to children affected by recurrent anaplastic ependymomas .</sentence>
<sentence id="8">All ependymomas <scope type="neg" id="1"><cue type="neg" id="1">lacked</cue> MGMT promoter hypermethylation and 9 ( 75 % ) showed high MGMT protein expression ( > 50 % tumoral cells )</scope> .</sentence>
<sentence id="9"><scope type="neg" id="2">Differences between different recurrences in the same patient were <cue type="neg" id="2">not</cue> observed</scope> .</sentence>
<sentence id="10">These results <scope type="spec" id="3"> <cue type="spec" id="3">may</cue> <scope type="spec" id="4"> <cue type="spec" id="4">indicate</cue> MGMT as a factor of chemoresistance to alkylating drugs in anaplastic ependymomas</scope> and support the uncertainties regarding the actual benefit of chemotherapy for patients with anaplastic ependymomas</scope> .</sentence>